Stay updated on Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.

Latest updates to the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.3. This change reflects a newer build of the page content rather than a substantive modification.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study page now indicates it is no longer recruiting participants, and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, while the Intervention/Treatment header was renamed from Intervention / Treatment and the revision label updated to v3.6.0.SummaryDifference0.3%

- Check25 days agoChange DetectedThe study plan now includes a new Sample Collection section added on 2026-06-02 as part of revision 3.5.5, superseding revision 3.5.4.SummaryDifference0.2%

- Check39 days agoChange DetectedGainesville site name was updated from University of Florida Health Science Center - Gainesville to UF Health Cancer Institute - Gainesville, and new entries for Diagnostic CAT Scan Service Type and Diagnostic CAT Scan were added to the imaging services.SummaryDifference0.3%

- Check47 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a small update to the page metadata or formatting; the change does not modify the study details or primary content.SummaryDifference0.0%

- Check61 days agoChange DetectedThe study record now shows Results Posted on 2026-04-29 with updated outcomes (PFS, ORR, OS, adverse events) and provides the Informed Consent Form PDF and Study Protocol/SAP; prior entries like Results Submitted and shorter timeframes have been replaced with the new posted-results status and extended timeframes.SummaryDifference1%

Stay in the know with updates to Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.